Search people, articles, bills, and more
The House passed the HALT Fentanyl Act to permanently classify fentanyl-related substances as high-restriction Schedule I drugs. The bipartisan vote aims to curb drug trafficking while easing rules for medical research on these substances. The bill now moves to the Senate.
This bill, known as the HALT Fentanyl Act (H.R. 27), aims to address the opioid crisis by permanently placing all fentanyl-related substances into Schedule I of the Controlled Substances Act. This classification is reserved for drugs with a high potential for abuse and no accepted medical use. By creating a broad chemical definition for these substances, the bill ensures that new variations of fentanyl are automatically restricted without requiring individual laws for every minor chemical change made by manufacturers. A passage vote is the final step for a bill in this chamber. In the House, most bills require a simple majority—more "yes" than "no" votes—to pass. Because this vote was successful, the House has officially approved the measure and sent it to the Senate for further consideration. The bill passed with 312 votes, reflecting a broad bipartisan coalition. Supporters argue it provides law enforcement with permanent tools to combat drug trafficking, while also including provisions to reduce administrative hurdles for scientists conducting research on these substances. The bill now moves to the Senate, where it must be approved before it can reach the President's desk.
The bill moves to the Senate, where it has been referred to the Committee on the Judiciary for review.
OPEN BILL →Why it matters. This legislation seeks to close legal loopholes used by drug traffickers while accelerating research into treatments for the fentanyl crisis.
Who’s affected. Law Enforcement: Provides permanent authority to prosecute traffickers of fentanyl analogs without waiting for individual substances to be scheduled. · Medical Researchers: Reduces administrative hurdles for studying Schedule I substances, potentially speeding up drug development. · Drug Traffickers: Faces stricter federal penalties for a wider variety of fentanyl-related chemical compounds.
Democrats. A majority of the Democratic caucus (153) supported the bill, while 50 members voted against it.
Republicans. The Republican caucus was nearly unanimous in its support, with 208 members voting in favor and only 7 voting against.
On Passage
Feb 6, 2025
The House passed the HALT Fentanyl Act to permanently classify fentanyl-related substances as high-restriction Schedule I drugs.
The bipartisan vote aims to curb drug trafficking while easing rules for medical research on these substances. The bill now moves to the Senate.
This was a final vote on whether the House of Representatives should approve this specific piece of legislation. In this case, a simple majority of members present and voting was required for the bill to pass and move to the next stage of the legislative process.
The bill moves to the Senate, where it has been referred to the Committee on the Judiciary for review.
This legislation seeks to close legal loopholes used by drug traffickers while accelerating research into treatments for the fentanyl crisis.
The bill passed with a strong bipartisan majority, receiving support from nearly all Republicans and a significant majority of Democrats.
A majority of the Democratic caucus (153) supported the bill, while 50 members voted against it.
The Republican caucus was nearly unanimous in its support, with 208 members voting in favor and only 7 voting against.
The lone independent member voted in favor of the bill.